The firm acts on some of Japan’s most prominent transactions, including Bain Capital's $3.3 billion pharma acquisition of ...
This sightseeing pass includes entry to top Tokyo attractions including Tokyo Tower, Tokyo Skytree, teamLab Planets and more ...